A 2015 study established that innate immune tumor-necrosis-factor (TNF) signaling is sensed by the hypothalamus, which engages the sympathetic nervous system to drive adipose lipolysis, releasing long-chain fatty acids and leptin that together rapidly expand peripheral T- and B-lymphocyte numbers during bacterial infection. The mechanistic interior of this brain–fat axis remains unmapped: the molecular and cellular basis of the cooperative action between fatty acids and leptin, the identity of any additional adipose-secreted mediators, and the mechanism by which obesity-associated chronic hypothalamic inflammation desensitizes hypothalamic TNF responsiveness and disables the axis are all still open.

Background

Innate immune responses to infection produce inflammatory cytokines such as tumor-necrosis factor (TNF), which are required to prime the slower adaptive immune response of T and B lymphocytes (typically developing over 4–7 days in mice). Kim et al. (Nature Immunology, 2015) asked whether the brain participates in this linkage. They found that after intravenous Listeria monocytogenes infection in mice, TNF levels in the brain rose quickly, and that delivering TNF directly into the brain was sufficient to increase the number of peripheral lymphocytes, especially in the spleen and epididymal fat, within days. Using TNF-receptor knockout mice, lentiviral TNF-receptor re-expression, and knockdown targeted to the mediobasal hypothalamus (MBH — a hypothalamic region whose surrounding blood–brain barrier is partially permeable to circulating signals), they showed that hypothalamic TNF receptor signaling, not TNF sensing elsewhere, was responsible. Pharmacological and surgical approaches indicated the sympathetic nervous system (SNS — the thoracolumbar autonomic branch whose noradrenergic fibers innervate adipose tissue) relays the signal: sympathetic induction of lipolysis (breakdown of triglycerides in adipocytes) released long-chain free fatty acids (FFAs) that were necessary and, with linoleic acid or palmitate injections, sufficient to increase T- and B-cell numbers. Because infection-induced lipolysis, unlike starvation-induced lipolysis, is accompanied by adipose release of the adipokine leptin (a hormone with known immune-enhancing effects), the authors also tested interdependence: inhibiting lipolysis with cerulenin blocked recombinant leptin from increasing lymphocytes, and neutralizing systemic leptin compromised palmitate's ability to increase T and B cells. They concluded that fatty acid and leptin release cooperate, while explicitly stating that the underlying signaling steps remain to be explored and that other, still-unidentified adipose-secreted factors may mediate the effect. Finally, in mice made obese by 15 weeks of high-fat feeding — a condition of chronic low-grade hypothalamic inflammation — low-dose hypothalamic TNF no longer raised adipose or splenic T and B cells, and TNF-inducible inflammatory genes in the hypothalamus (Nfkbia, Il1b, Il6, Socs3) showed elevated baseline but negligible induction, i.e., a desensitized hypothalamic TNF response whose cell types and intracellular pathways were not further characterized. This background connects to two adjacent literatures. First, fatty-acid metabolism is known to support lymphocyte biology — for example, memory CD8+ T cells rely on cell-intrinsic lipolysis and fatty-acid oxidation for their metabolic programming (O’Sullivan et al., Immunity, 2014). Second, brain control of adaptive immunity has since been demonstrated mechanistically along an anatomically different route: Zhang et al. (Nature, 2020) showed that corticotropin-releasing-hormone neurons in the central amygdala and paraventricular nucleus act through the splenic nerve, acetylcholine-producing T cells, and B-cell α9 nicotinic receptors to enhance plasma-cell and antibody responses. Separately, Bergin et al. (Brain, Behavior, and Immunity, 2021) identified a parallel hypothalamic-to-adipose immune axis — hypothalamic BDNF (brain-derived neurotrophic factor) acting through sympathetic β-adrenergic signaling to induce adipocyte interleukin-15 (IL-15), which expands adipose natural killer cells — and adipose tissue is well established as a local B-cell support niche via fat-associated lymphoid clusters (FALCs; Bénézech et al., 2015). None of these, however, addresses the adipose-mediated route from innate TNF sensing to T/B-cell expansion, its adipokine cooperation, or its obesity-induced failure.

Problem Statement

Define the molecular and cellular mechanism by which the hypothalamus–fat axis converts innate TNF signaling into a rapid increase of peripheral T and B lymphocytes, and how this axis fails in obesity. Concretely, a complete answer must: (1) identify the receptors, signaling pathways, and responding cell types through which adipose-released long-chain free fatty acids and leptin cooperate — as demonstrated by the interdependence of palmitate/linoleic acid and leptin effects on T- and B-cell numbers — to expand peripheral lymphocyte numbers, distinguishing lymphocyte-intrinsic metabolic action from effects relayed through stromal or innate immune cells in adipose tissue and spleen; (2) determine whether adipose-secreted factor(s) beyond free fatty acids and leptin participate in hypothalamus-induced lymphocyte mobilization; and (3) identify the hypothalamic cell types and intracellular pathways responsible for the desensitization of hypothalamic TNF responsiveness under diet-induced obesity/chronic hypothalamic inflammation that abolishes the axis's lymphocyte-mobilizing effect. The three components jointly support one objective — a causal, receptor-level mechanistic account of the brain–fat axis's immune function in health and its failure in obesity — spanning the causal chain established by the source study (hypothalamic TNF sensing → sympathetic outflow → adipocyte lipolysis and adipokine release → lymphocyte expansion).

References

  1. Kim MS, Yan J, Wu W, Zhang G, Zhang Y, Cai D. Rapid linkage of innate immunological signals to adaptive immunity by the brain-fat axis. Nature Immunology 16(5):525–533 (2015). doi:10.1038/ni.3133. https://doi.org/10.1038/ni.3133
  2. Gadani SP, Kipnis J. Brainless immunity no more. Nature Immunology 16(5):440–441 (2015). doi:10.1038/ni.3145. https://doi.org/10.1038/ni.3145
  3. Leavy O. Immune regulation: Brain–fat axis in adaptive immunity. Nature Reviews Immunology 15:267 (2015). doi:10.1038/nri3853. https://doi.org/10.1038/nri3853
  4. O’Sullivan D, van der Windt GJW, Huang SC, Curtis JD, Chang CH, Buck MD, Qiu J, Smith AM, Lam WY, DiPlato LM, Hsu FF, Birnbaum MJ, Pearce EJ, Pearce EL. Memory CD8+ T cells use cell-intrinsic lipolysis to support the metabolic programming necessary for development. Immunity 41(1):75–88 (2014). doi:10.1016/j.immuni.2014.06.005. https://doi.org/10.1016/j.immuni.2014.06.005
  5. Zhang X, Lei B, Yuan Y, Zhang L, Hu L, Jin S, Kang B, Liao X, Sun W, Xu F, Zhong Y, Hu J, Qi H. Brain control of humoral immune responses amenable to behavioural modulation. Nature 581(7807):204–208 (2020). doi:10.1038/s41586-020-2235-7. https://doi.org/10.1038/s41586-020-2235-7
  6. Bergin SM, Xiao R, Huang W, Judd CRT, Liu X, Mansour AG, Queen N, Widstrom KJ, Caligiuri MA, Cao L. Environmental activation of a hypothalamic BDNF-adipocyte IL-15 axis regulates adipose-natural killer cells. Brain, Behavior, and Immunity 95:477–488 (2021). doi:10.1016/j.bbi.2021.05.005. https://doi.org/10.1016/j.bbi.2021.05.005
  7. Bénézech C, Luu NT, Walker JA, Kruglov AA, Loo Y, Nakamura K, Zhang Y, Nayar S, Jones LH, Flores-Langarica A, McIntosh A, Marshall J, Barone F, Besra G, Miles K, Allen JE, Gray M, Kollias G, Cunningham AF, Withers DR, Toellner KM, Jones ND, Veldhoen M, Nedospasov SA, McKenzie ANJ, Caamaño JH. Inflammation-induced formation of fat-associated lymphoid clusters. Nature Immunology 16(8):819–828 (2015). doi:10.1038/ni.3215. https://doi.org/10.1038/ni.3215
  8. Daley AD, Bénézech C. Fat-associated lymphoid clusters: Supporting visceral adipose tissue B cell function in immunity and metabolism. Immunological Reviews 324(1):78–94 (2024). doi:10.1111/imr.13339. https://doi.org/10.1111/imr.13339
  9. Cai D, Khor S. "Hypothalamic Microinflammation" Paradigm in Aging and Metabolic Diseases. Cell Metabolism 30(1):19–35 (2019). doi:10.1016/j.cmet.2019.05.021. https://doi.org/10.1016/j.cmet.2019.05.021
  10. Izumi M, Nakanishi Y, Kang S, Kumanogoh A. Peripheral and central regulation of neuro-immune crosstalk. Inflammation and Regeneration 44(1):41 (2024). doi:10.1186/s41232-024-00352-3. https://doi.org/10.1186/s41232-024-00352-3
  11. Lee CH. Neuro-immune interactions in metabolic regulation: brain and adipose tissue crosstalk. Journal of Obesity and Metabolic Syndrome 34(3):182–195 (2025). doi:10.7570/jomes25050. https://doi.org/10.7570/jomes25050